CORD-19:e847d433e7424152a9846673209cb73027415ecd / 431059-431307 JSONTXT

Annnotations TAB JSON ListView MergeView

    CORD-19-Sentences

    {"project":"CORD-19-Sentences","denotations":[{"id":"TextSentencer_T3955","span":{"begin":0,"end":248},"obj":"Sentence"},{"id":"T30951","span":{"begin":0,"end":248},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"5'UTR Seq provided subtype determination in 96% of the clinical samples (24/25; one sample subtype 5a by InnoLiPA was classified as type 4r/4m without further subtyping), while InnoLiPA accounted for subtyping 13 of 25 samples (52% of all samples)."}

    CORD-19_Custom_license_subset

    {"project":"CORD-19_Custom_license_subset","denotations":[{"id":"T417","span":{"begin":0,"end":248},"obj":"Sentence"}],"text":"5'UTR Seq provided subtype determination in 96% of the clinical samples (24/25; one sample subtype 5a by InnoLiPA was classified as type 4r/4m without further subtyping), while InnoLiPA accounted for subtyping 13 of 25 samples (52% of all samples)."}